Join
Live feed
·
INSIDERFilingvia Quantisnow
KalVista Pharmaceuticals Inc. logo

CHIEF EXECUTIVE OFFICER Palleiko Benjamin L converted options into 2,419 shares and sold $15,570 worth of shares (1,038 units at $15.00), increasing direct ownership by 0.32% to 429,667 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track KALV (KalVista Pharmaceuticals Inc.) and more on Quantisnow.